Financial statements Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawex
Balance sheet data of PRZEDSIĘBIORSTWO DYSTRYBUCJI FARMACEUTYCZNEJ SLAWEX
Year
|
2018
|
2019
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|
Total assets | 457 923 974,04 | 461 266 475,23 | 552 465 393,34 | 655 743 858,81 | 751 630 126,57 |
A. Fixed assets | 59 075 404,11 | 58 766 006,22 | 69 271 401,14 | 69 244 921,34 | 119 829 850,48 |
B. Current assets | 398 848 569,93 | 402 500 469,01 | 483 193 992,20 | 586 498 937,47 | 631 800 276,09 |
C. Share capital contributions (basic funds) | - | - | - | - | - |
D. Own shares (stocks) | - | - | - | - | - |
Total liabilities | 457 923 974,04 | 461 266 475,23 | 552 465 393,34 | 655 743 858,81 | 751 630 126,57 |
A. Equity | 101 469 275,05 | 106 562 060,51 | 117 245 514,29 | 121 374 618,91 | 127 641 294,06 |
B. Liabilities and provisions for liabilities | 356 454 698,99 | 354 704 414,72 | 435 219 879,05 | 534 369 239,90 | 623 988 832,51 |
I. Long-term liabilities | 24 534 243,00 | 50 150 705,33 | 62 190 801,74 | 93 372 646,21 | 37 047 597,83 |
II. Short-term liabilities | 329 400 201,11 | 302 108 129,45 | 369 441 805,15 | 429 061 118,00 | 573 904 933,68 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.